Xenon Pharmaceuticals XENE Q1 2025 earnings
Reported May 12, 2025 · After market close
Revenue$7.5MBeat by $5.6M
EPS-$0.83Beat by $0.11
Revenue estimate$1.9M
EPS estimate-$0.94
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$1.7M
EPS estimate-$1.16
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Q1 2025$7.5MBeat by $5.6M
Diluted EPS
Ask the moment Xenon Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Xenon Pharmaceuticals report Q1 2025 earnings?
- Xenon Pharmaceuticals (XENE) reported Q1 2025 earnings on May 12, 2025 after market close.
- What were Xenon Pharmaceuticals's Q1 2025 revenue and EPS?
- Xenon Pharmaceuticals reported revenue of $7.5M and eps of $-0.83 for Q1 2025.
- Did Xenon Pharmaceuticals beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $1.9M by $5.6M. EPS beat the consensus estimate of $-0.94 by $0.11.
- How did Xenon Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 33.9% from $-0.62.
- Where can I find Xenon Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-069342) directly on SEC EDGAR. The filing index links above go to sec.gov.